Patient perspectives on nipple-areola complex micropigmentation during the COVID-19 pandemic

BACKGROUND: Micropigmentation is a well-recognised option for nipple-areola complex reconstruction, as part of the breast reconstruction pathway for patients following mastectomy. As a part of delayed breast reconstruction, this treatment was put on hold during the COVID-19 pandemic. AIMS: To assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Frost, S., Pilley, M., Porter, C., Agarwal, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. 2022
Materias:
Correspondence and Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225963/
https://www.ncbi.nlm.nih.gov/pubmed/35780000
http://dx.doi.org/10.1016/j.bjps.2022.06.032
Descripción
Sumario:BACKGROUND: Micropigmentation is a well-recognised option for nipple-areola complex reconstruction, as part of the breast reconstruction pathway for patients following mastectomy. As a part of delayed breast reconstruction, this treatment was put on hold during the COVID-19 pandemic. AIMS: To assess the views of patients regarding micropigmentation in response to the COVID-19 pandemic, and whether their attitudes to seeking out this part of the reconstructive journey had been altered. METHODS: A questionnaire undertaken with 53 patients between August & September 2020 attending the Micropigmentation clinic. FINDINGS: 81.1% of patients reported COVID-19 had not impacted their decision, with a similar proportion happy to proceed with the treatment at the time of questioning. CONCLUSIONS: The results highlight the importance of nipple-areola complex to our patients’ reconstructive journey.

Ejemplares similares